Ukrainian Medical Stomatological Academy
Quick facts
Marketed products
Phase 3 pipeline
- Oral L-arginine aspartate administration · Cardiovascular
L-arginine aspartate is a nitric oxide precursor that enhances endothelial function and vascular reactivity through increased NO production. - Oral L-ornithine aspartate administration · Gastroenterology
Oral L-ornithine aspartate administration increases ornithine levels in the body.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Ukrainian Medical Stomatological Academy portfolio CI brief
- Ukrainian Medical Stomatological Academy pipeline updates RSS
Frequently asked questions about Ukrainian Medical Stomatological Academy
What are Ukrainian Medical Stomatological Academy's marketed drugs?
Top marketed products include Ramipril 5 MG.
What is Ukrainian Medical Stomatological Academy's pipeline?
Ukrainian Medical Stomatological Academy has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Oral L-arginine aspartate administration, Oral L-ornithine aspartate administration.
Related
- Ramipril 5 MG
- Sector hub: All tracked pharma companies